Literature DB >> 15656711

Inflammatory bowel disease. Part II: Crohn's disease--pathophysiology and conventional and alternative treatment options.

Kathleen Head, Julie S Jurenka.   

Abstract

Crohn's disease, a subcategory of inflammatory bowel disease, contributes to significant morbidity, particularly in industrialized nations. It can affect people of any age, but is more commonly diagnosed in adolescence and young adulthood. Inflammation and ulceration occurs primarily in the terminal ileum and colon, although any portion of the intestinal tract can be affected. No etiology has been identified for Crohn's disease, although a number of factors contribute to its etiopathogenesis, including genetic, microbial, inflammatory, immune, and permeability abnormalities. Conventional medications are not curative but can contribute to resolution of acute flare-ups and help maintain remission. Because significant side effects are associated with many these medications, more natural interventions to help maintain remission should be considered. Associated nutrient deficiencies, dietary interventions, and nutrient and botanical supplementation are discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15656711

Source DB:  PubMed          Journal:  Altern Med Rev        ISSN: 1089-5159


  19 in total

1.  Resveratrol suppresses colitis and colon cancer associated with colitis.

Authors:  Xiangli Cui; Yu Jin; Anne B Hofseth; Edsel Pena; Joshua Habiger; Alexander Chumanevich; Deepak Poudyal; Mitzi Nagarkatti; Prakash S Nagarkatti; Udai P Singh; Lorne J Hofseth
Journal:  Cancer Prev Res (Phila)       Date:  2010-03-23

2.  Anti-inflammatory Effects of Ganoderma lucidum Triterpenoid in Human Crohn's Disease Associated with Downregulation of NF-κB Signaling.

Authors:  Changda Liu; David Dunkin; Joanne Lai; Ying Song; Clare Ceballos; Keith Benkov; Xiu-Min Li
Journal:  Inflamm Bowel Dis       Date:  2015-08       Impact factor: 5.325

3.  Role of resveratrol-induced CD11b(+) Gr-1(+) myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3(+) T cells and amelioration of chronic colitis in IL-10(-/-) mice.

Authors:  Udai P Singh; Narendra P Singh; Balwan Singh; Lorne J Hofseth; Dennis D Taub; Robert L Price; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Brain Behav Immun       Date:  2011-07-23       Impact factor: 7.217

4.  Anti-inflammatory effects of the Chinese herbal formula FAHF-2 in experimental and human IBD.

Authors:  Ying Song; David Dunkin; Stephanie Dahan; Alina Iuga; Clare Ceballos; Kathy Hoffstadter-Thal; Nan Yang; Keith Benkov; Lloyd Mayer; Xiu-Min Li
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

5.  An unusual presentation of fistulating Crohn's disease: Ascites.

Authors:  Richard Kia; David White; Sanchoy Sarkar
Journal:  World J Gastrointest Endosc       Date:  2010-01-16

6.  Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease.

Authors:  Jenna M Benson; David M Shepherd
Journal:  Toxicol Sci       Date:  2010-12-03       Impact factor: 4.849

7.  Apple polyphenols require T cells to ameliorate dextran sulfate sodium-induced colitis and dampen proinflammatory cytokine expression.

Authors:  Jerod A Skyberg; Amy Robison; Sarah Golden; Maryclare F Rollins; Gayle Callis; Eduardo Huarte; Irina Kochetkova; Mark A Jutila; David W Pascual
Journal:  J Leukoc Biol       Date:  2011-06-21       Impact factor: 4.962

8.  Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis.

Authors:  Venkata S Kotakadi; Yu Jin; Anne B Hofseth; Lei Ying; Xiangli Cui; Suresh Volate; Alexander Chumanevich; Patricia A Wood; Robert L Price; Anna McNeal; Udai P Singh; Narendra P Singh; Mitzi Nagarkatti; Prakash S Nagarkatti; Lydia E Matesic; Karine Auclair; Michael J Wargovich; Lorne J Hofseth
Journal:  Carcinogenesis       Date:  2008-06-20       Impact factor: 4.944

9.  Effects of an Oral Supplementation of Germinated Barley Foodstuff on Serum CRP Level and Clinical Signs in Patients with Ulcerative Colitis.

Authors:  Zeinab Faghfoori; Rahebeh Shakerhosseini; Lida Navai; Mohammad Hossein Somi; Zeinab Nikniaz; Alireza Abadi
Journal:  Health Promot Perspect       Date:  2014-07-12

10.  Resveratrol (trans-3,5,4'-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitis.

Authors:  Udai P Singh; Narendra P Singh; Balwan Singh; Lorne J Hofseth; Robert L Price; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2009-11-25       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.